Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Microb Pathog ; 121: 155-165, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29778820

RESUMO

The present study was aimed to evaluate the antimicrobial activities of bioactive compounds synthesized from vermicast isolated actinomycetes species. Specifically, the synthesized bioactive compounds were evaluated for their antimicrobial activity against selected Gram + ve and Gram - ve human pathogenic bacteria including Staphylococcus aureus, Bacillus circulans, Bacillus subtilis, Pseudomonas aeruginosa, and Escherichia coli. Interestingly, a total of five different actinomycetes species were recovered from vermicasts. More interestingly, among these potential actinomycetes species, the bioactive compounds synthesized by isolate AS9 showed a significant antibacterial activity and its mean zone of inhibition was found at 11.3 ±â€¯1.6 mm, 9.5 ±â€¯0.91 mm, and 9.9 ±â€¯1.71mm against S. aureus, B. subtilis, and B. circulans, respectively. Furthermore, according to antibacterial activity and spectrum broadness, three of the actinomycetes strains were selected and characterized by conventional methods. Subsequently, the bioactive compound profiling of these isolated actinomycetes strains performed through GC-MS analysis indicating the presence of the bioactive compounds including 3, octadecene (E), behnic alcohol phenol, 2,4-bis(1,1-dimethyl ethyl) 1-nonadecene, 1-heneicosanol, milbemycin 3-eicosene (E), and 1-docosanol.


Assuntos
Actinobacteria/metabolismo , Antibacterianos/farmacologia , Actinobacteria/classificação , Actinobacteria/isolamento & purificação , Antibacterianos/isolamento & purificação , Bacillus/efeitos dos fármacos , Bacillus subtilis/efeitos dos fármacos , DNA Bacteriano/genética , Escherichia coli/efeitos dos fármacos , Escherichia coli/metabolismo , Cromatografia Gasosa-Espectrometria de Massas , Índia , Filogenia , Pseudomonas aeruginosa/efeitos dos fármacos , RNA Ribossômico 16S/genética , Espectroscopia de Infravermelho com Transformada de Fourier , Staphylococcus aureus/efeitos dos fármacos
2.
Spectrochim Acta A Mol Biomol Spectrosc ; 133: 785-93, 2014 Dec 10.
Artigo em Inglês | MEDLINE | ID: mdl-24998685

RESUMO

A series of heteroleptic copper(II) complexes of the type [CuL(1-4)(diimine)](ClO4)2 (1-8) [L(1-4)=2-((2-(piperazin-1-yl)ethylimino)methyl)-4-substituted phenols, and diimine=2,2'-bipyridyl (bpy) or 1,10-phenanthroline (phen)], have been synthesized and characterized by spectroscopic methods. The IR spectra of complexes indicate the presence of uncoordinated perchlorate anions and the electronic spectra revealed the square pyramidal geometry with N4O coordination environment around copper(II) nuclei. Electrochemical studies of the mononuclear complexes evidenced one-electron irreversible reduction wave in the cathodic region. The EPR spectra of complexes with g|| (2.206-2.214) and A|| (154-172×10(-)(4)cm(-)(1)) values support the square-based CuN3O coordination chromophore and the presence of unpaired electron localized in [Formula: see text] ground state. Antioxidant studies against DPPH revealed effective radical scavenging properties of the synthesized complexes. Binding studies suggest that the heteroleptic copper(II) complexes interact with calf thymus DNA (CT-DNA) through minor-groove and electrostatic interaction, and all the complexes display pronounced nuclease activity against supercoiled pBR322 DNA.


Assuntos
Antioxidantes/química , Complexos de Coordenação/química , Cobre/química , DNA/metabolismo , Fenóis/química , Animais , Antioxidantes/farmacologia , Bovinos , Complexos de Coordenação/farmacologia , Cobre/farmacologia , DNA/química , Clivagem do DNA/efeitos dos fármacos , Desoxirribonucleases/química , Fenóis/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA